Clinical impact of phosphorylated signal transducer and activator of transcription 3, epidermal growth factor receptor, p53, and vascular endothelial growth factor receptor 1 expression in resected adenocarcinoma of lung by using tissue microarray
Hyeong Su Kim(Zero to Three), Myung‐Ju Ahn(Samsung Medical Center)
Cited by 36
Related Papers
MDSC subtypes and CD39 expression on CD8 <sup>+</sup> T cells predict the efficacy of anti‐PD‐1 immunotherapy in patients with advanced NSCLC
|European Journal of Immunology|2020|90
Entrectinib resistance mechanisms in ROS1-rearranged non-small cell lung cancer
|Investigational New Drugs|2019|50
CpG oligodeoxynucleotides induce IL-8 expression in CD34+ cells via mitogen-activated protein kinase-dependent and NF-κB-independent pathways
|International Immunology|2005|40
Mutational status of <i>TP53</i> defines the efficacy of Wee1 inhibitor AZD1775 in <i>KRAS</i>-mutant non-small cell lung cancer
|Oncotarget|2017|40
ERK inhibitor ASN007 effectively overcomes acquired resistance to EGFR inhibitor in non‐small cell lung cancer
|Investigational New Drugs|2022|8